Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Recruiting now Phase 3 NCT07177352
Run by Hoffmann-La Roche · for 50 to 90 · All sexes
What this study is about
This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease studies.
Who can join (things the study team will check)
✅ You may be able to join if…
- Report of objective or subjective memory concerns (by the participant and/or their informant) within the last year with or without a previous clinical diagnosis of MCI or dementia due to AD.
🚫 You may not be able to join if…
- Dependency in basic activities of daily living (bADLs) due to cognitive impairment
- Visual or auditory impairment that would prevent them from performing the cognitive assessments (eyeglasses and hearing aids are permitted)
- Any self-reported evidence or known diagnosis of a neurological or neurodegenerative condition that may lead to cognitive impairment other than AD
- History of severe, clinically significant central nervous system trauma
- Any serious medical condition that precludes a participant's safe participation and completion of a clinical study
Where this trial is running
- University of Alabama at Birmingham, Birmingham, Alabama, United States
- Banner Alzheimer?s Institute, Phoenix, Arizona, United States
- Banner Sun Health Research Institute, Sun City, Arizona, United States
- Sun Valley Research Center, Inc., Imperial, California, United States
- Inglewood Clinicals, Inglewood, California, United States
- Irvine Center for Clinical Research, Irvine, California, United States
- Healthy Brain Clinic, Long Beach, California, United States
- Oakland Clinical, Oakland, California, United States
- Riverside Clinical, Riverside, California, United States
- Syrentis Clinical Research, Santa Ana, California, United States
- Cenexel California Neuroscience Research, LLC, Sherman Oaks, California, United States
- Yale University, New Haven, Connecticut, United States
+ 199 more sites.
Who to contact
Reference Study ID Number: WP45722 https://forpatients.roche.com/ No attachments to email below. · 888-662-6728 (U.S. and Canada) · global-roche-genentech-trials@gene.com
It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT07177352.
Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.
Beacon is an information tool, not medical advice. Whether a trial is right for you is a decision for you, your doctor, and the study team. Trial details come from the official registry, ClinicalTrials.gov, and may change — always confirm with the study team. Beacon collects no data about you: this page has no cookies, no accounts, and no tracking.